🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
VIS
$VISTN.OL
🔒 EuropeVistin Pharma ASA
AVG HISTORICAL GAP
+0.58%
MAX GAP RECORD
+2.70%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $VISTN.OL
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$VISTN.OL
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 29, 2026 Earnings Release 2026-10-29 (BEFORE OPEN) |
+0.00%
|
| Aug 20, 2026 Earnings Release 2026-08-20 (AFTER CLOSE) |
-1.55%
|
| Apr 24, 2026 Earnings Release 2026-04-24 (AFTER CLOSE) |
+2.70%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
2.1%
Bullish Gaps (1)
Bearish Gaps (1)
Neutral / Flat (0)
📖 Intelligence Summary
Vistin Pharma ASA is a pharmaceutical company, which engages in the production of Metformin Active Pharmaceutical Ingredients (API). It offers Metformin HCI and Metformin DC. The company was founded on March 6, 2015 and is headquartered in Oslo, Norway.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗